Head of Toxicology, Integrated DMPK & Safety, Research & Development
Orion · Turku, Espoo
Full-time · Posted on 18 November 2026
Apply on the original site (opens in a new tab)Open in FullTime with Benefits
Orion Corporation (Orion Pharma) is a well-established, financially stable pharmaceutical company operating in more than 35 countries, including our recently established R&D hubs in Cambridge, USA and Cambridge, UK. We are now seeking an experienced scientific leader to lead the Toxicology and Integrated DMPK & Safety organization in Orion Pharma's Research & Development organisation.
In this senior leadership role, you will provide strategic direction for Orion Pharma’s Integrated DMPK & Safety department responsible for preclinical DMKP and safety and toxicology functions including in vivo facilities. You will foster a culture of innovation, collaboration, and scientific excellence while driving robust nonclinical DMPK & safety strategies that support all stages of drug development. Your deep expertise across key safety disciplines—such as general toxicology, safety pharmacology, genotoxicity, reproductive toxicology, and carcinogenicity—will ensure high-quality decision-making that aligns with Orion’s scientific and business objectives.
Key Responsibilities
Oversee the design, execution, and critical interpretation of in vitro and in vivo nonclinical DMPK, bioanalytics & safety studies to support drug discovery projects.
Provide integrated strategic direction for all nonclinical DMPK & safety activities supporting molecular discovery, preclinical development, and clinical progression.
Lead and develop a high performing team of pharmacologists, toxicologists and pathologists, cultivating an environment that encourages scientific curiosity, collaboration, and continuous learning.
Apply comprehensive knowledge of nonclinical DMPK & safety disciplines and their integration across the business to support Orion’s competitive differentiation.
Anticipate and evaluate DMPK & safety challenges in a fast evolving scientific and regulatory landscape, driving innovative, forward-looking solutions.
Partner closely with cross functional teams to guide and coach colleagues in the development of scientifically sound nonclinical safety strategies.
Apply advanced scientific and regulatory writing skills to review and author nonclinical components of regulatory submissions (INDs, CTAs, BLAs, MAAs) and health authority interaction documents. Ensure alignment of pharmacology and toxicology input with clinical and regulatory strategies.
Prepare and present related data and right interpretations of data to project teams, governance groups, external partners, and scientific stakeholders.
Influence multiple complex development programs through strong cross functional leadership, sound scientific judgment, and effective communication with discovery, development, and regulatory partners.
Collaborate closely with research, clinical development, DMPK, bioanalytics, clinical safety, and regulatory colleagues to ensure holistic, high-quality safety assessments. Serve as a key voice in regulatory agency interactions and internal governance discussions.
Maintain an active scientific presence internally and externally by supporting publications, presenting at scientific conferences, and engaging with experts and the broader scientific community.
In addition to leading the line function, contribute as an independent scientific expert for selected discovery, development, or in licensing programs as the designated functional representative.
This role is a member of RD leadership team and reports to the Executive Vice President of Research & Development organisation. As a member of RD LT, broad and deep scientific and strategic contribution to the whole R&D is an important part of the role.
The position can be based in Cambridge, UK or in Espoo or Turku, Finland. Relocation support is available.
What We Offer
At Orion Pharma, we provide a dynamic and innovative research environment where your expertise will directly shape the future of our preclinical safety & toxicology function. Our culture is built on mutual respect, scientific excellence, and continuous learning—supporting a sense of purpose, belonging, and shared achievement. With collaboration spanning global teams, you will have the space to influence meaningful scientific and organisational impact.
We offer competitive compensation and a comprehensive benefits package designed to support your professional and personal wellbeing.
Learn more about our values and what it’s like to work at Orion Pharma:
https://www.orion.fi/en/careers/orion-as-an-employer/
Flexible hybrid work is available in line with Orion’s guidelines.
Our Expectations
DVM or PhD in toxicology, pathology, pharmacology, immunology, or another relevant scientific field.
Extensive experience (15+ years) in biotech/pharmaceutical settings within preclinical safety evaluation, ideally in oncology and pain, across multiple modalities (e.g., SMEs, bsAbs, ADCs, CARTs).
Demonstrated experience serving as, or managing teams serving as, the Toxicology representative on discovery and development programs.
Proven track record in designing and executing nonclinical toxicology strategies and studies to support clinical development and regulatory submissions.
Experience in developing and mentoring scientific talent and guiding teams in nonclinical safety strategy.
Strong knowledge of FDA, ICH, and GLP requirements related to toxicology and safety pharmacology.
Hands‑on experience writing and reviewing nonclinical components of regulatory submissions and interacting with global health authorities.
A passion for people leadership, team development, and organisational growth.
Excellent written and verbal communication skills, with the ability to deliver clear and concise scientific presentations.
Additional Information
If this role aligns with your interests and aspirations, we encourage you to apply no later than November 30th, 2026.
This recruitment process is conducted in collaboration with an external recruitment partner, and by submitting your application to Orion Pharma, you consent to your personal data being processed by the appointed recruitment agency for the purposes of this hiring process. Please note that only candidates whose background and experience are considered suitable will be contacted.
#LI-ORION
Orion’s pharmaceutical innovations are created within its R&D organization. We employ top professionals in the field of drug discovery and development. We work globally: in Espoo and Turku in Finland, in Cambridge and Nottingham in England and in Cambridge, USA. Orion R&D and the Innovative Medicines business division are dedicated to becoming a global player in oncology and pain therapy areas.
About the company
Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years.
We’re home to more than 4,000 Orionees around the world, and we’re proud to be known as a responsible employer and a great place to work. At Orion Pharma, people are truly valued and trusted, encouraged to grow, and supported by a culture where every voice is heard. We appreciate each other, strive for excellence, and build the future.
Together we develop, manufacture, and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Our extensive portfolio includes proprietary and generic medicines as well as consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion Pharma are used to treat cancer, neurological diseases, respiratory diseases, and more.
We offer careers with a clear purpose: empowering people to live their lives to the fullest.
About Orion
Original posting: fa-esaq-saasfaprod1.fa.ocs.oraclecloud.com